Gilead to Boost Stake in Galapagos as Part of $5.1 Billion Deal

(Bloomberg) -- Gilead Sciences Inc. agreed to pay $5.1 billion to raise its stake in biotechnology company Galapagos NV to deepen its research into inflammatory diseases and other disorders, sendin...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.